manp
Peptideexperimental
Clinical trial activity
5 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 18, 2017 (NCT03781739)
Timeline
Indications
Mechanism of action
NPR1 activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06343298 | Phase 2 | Sep 25, 2024 | A*Star, Mayo Clinic, PPD |
| NCT05279742 | Phase 1/Phase 2 (Phase 2) | Nov 4, 2022 | Mayo Clinic |
| NCT05247528 | Phase 1 | Dec 20, 2021 | A*Star, Integrium, Mayo Clinic |
| NCT04542681 | Phase 1 | May 1, 2018 | Mayo Clinic |
| NCT03781739 | Phase 1 | Aug 18, 2017 | American Heart Association, Mayo Clinic |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 5 | 3 | 2 | 2017 |
| A*Star | Government | 2 | 2 | 2 | 2021 |
| American Heart Association | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Integrium | For profit | 1 | 0 | 1 | 2021 |
| PPD | For profit | 1 | 0 | 1 | 2024 |
5 organizations
Page 1 / 1